Medindia13 分钟
YolTech Therapeutics to Initiate a Clinical Trial for YOLT-204, a First-in-Class Bone ...
YolTech Therapeutics, a clinical-stage gene editing company dedicated to delivering lifelong cures, announced the initiation of a clinical trial for YOLT-204 , an investigational ...